The Avocado Pit (TL;DR)
- 🚀 The fastest route to regulatory-grade AI isn't a DIY project or a shopping spree.
- 🤝 Mature pharma companies are blending build and buy strategies for AI success.
- 🏗️ Customization and control are key in navigating regulatory AI.
Why It Matters
In the world of regulatory-grade AI, the classic "build vs. buy" debate is like arguing whether a homemade avocado toast is better than one from a café—it misses the point entirely. The real conversation should be about how to get the best of both worlds. For industries like pharma, where the stakes are higher than an overripe avocado, combining internal innovation with external expertise is the way forward.
What This Means for You
If you're in the business of AI, especially in sectors where regulations reign supreme, it's time to rethink. The choice isn't just between rolling up your sleeves or whipping out your wallet. It's about strategically leveraging both to create AI that's not just compliant, but also competitive. So, start thinking about partnerships, customizations, and keeping a firm grip on the steering wheel of your AI journey.
The Source Code (Summary)
The original article from Yseop argues that the path to regulatory-grade AI doesn't fit neatly into "build" or "buy" categories. Instead, it suggests that mature pharmaceutical companies are successfully navigating the AI landscape by integrating both approaches. This blend allows them to maintain control while still benefiting from the innovations and speed that external solutions can offer.
Fresh Take
Forget the tired debate of build vs. buy—it's not the 90s anymore. In today's AI-driven world, especially where regulations are as complex as assembling IKEA furniture without instructions, the real magic happens in the blend. It's about having the flexibility of a custom-built solution with the efficiency of a ready-made one. So, let's stop labeling AI strategies like we're sorting laundry and focus on creating something that’s both smart and compliant. Because in the end, it's not just about having AI, it's about having the right AI.
Read the full Blog Archives - Yseop article → Click here
